Nephrogenic Diabetes Insipidus Management and Presentation

Pathophysiology and Presentation

Nephrogenic diabetes insipidus (NDI) is characterized by insensitivity of the distal nephron to arginine vasopressin (AVP), resulting in the kidney's inability to concentrate urine despite normal or elevated AVP levels 1
The hallmark symptoms of NDI include polyuria and polydipsia, which develop as compensatory mechanisms to prevent dehydration and hypernatremia 1
In properly compensated NDI, patients maintain normal serum sodium levels by drinking sufficient water to match their urinary losses 1

Most patients with NDI who have free access to water and intact thirst mechanisms will maintain normal serum sodium levels through compensatory polydipsia 1
The diagnosis of NDI is based on demonstrating inappropriately dilute urine (typically <200 mOsm/kg H₂O) in the presence of normal or elevated serum osmolality 1, 2
Initial biochemical workup should include serum sodium, serum osmolality, and urine osmolality 2

The cornerstone of NDI management is ensuring adequate free access to water 2
Pharmacological treatment includes thiazide diuretics, prostaglandin synthesis inhibitors, and amiloride 4
When initiating pharmacological treatment, careful monitoring is essential as paradoxical hyponatremia may develop if high fluid intake is maintained 2
Regular monitoring of electrolytes is recommended: every 2-3 months in infants, every 3-12 months in children, and annually in adults 3, 4

Patients with NDI are at higher risk of developing chronic kidney disease (CKD), with approximately 50% of adult patients having CKD stage ≥2 2
During illness or hospitalization, patients with NDI require special attention to fluid management, as standard protocols may not be appropriate for their condition 5
Isotonic fluids (0.9% NaCl) should be avoided in NDI patients with hypernatremia, as they increase renal osmotic load and can worsen the condition 3